tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFs
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

IDYA Stock Latest News

Optimistic Buy Rating for IDEAYA Biosciences: Expanding Market Potential and Promising Clinical Data
RatingsOptimistic Buy Rating for IDEAYA Biosciences: Expanding Market Potential and Promising Clinical Data
5d ago
IDYA
Ideaya Biosciences announces inducement grants under Nasdaq listing rule
PremiumThe Fly
Ideaya Biosciences announces inducement grants under Nasdaq listing rule
9d ago
IDYA
IDEAYA Biosciences: Buy Rating on Anticipated Success of Darovasertib Trial and Stock Appreciation Potential
PremiumRatings
IDEAYA Biosciences: Buy Rating on Anticipated Success of Darovasertib Trial and Stock Appreciation Potential
25d ago
IDYA
IDEAYA Biosciences: Promising Advancements and Strategic Initiatives Drive Buy Rating
PremiumRatings
IDEAYA Biosciences: Promising Advancements and Strategic Initiatives Drive Buy Rating
1M ago
IDYA
IDEAYA Biosciences: Hold Rating Amid Promising Trials and Uncertainties
PremiumRatings
IDEAYA Biosciences: Hold Rating Amid Promising Trials and Uncertainties
1M ago
IDYA
IDEAYA Biosciences Reports Q1 2025 Financial Results
PremiumCompany AnnouncementsIDEAYA Biosciences Reports Q1 2025 Financial Results
1M ago
IDYA
Ideaya Biosciences price target lowered to $37 from $40 at Oppenheimer
Premium
The Fly
Ideaya Biosciences price target lowered to $37 from $40 at Oppenheimer
1M ago
IDYA
Oncology stocks ‘bearing the brunt’ of Prasad news, says Oppenheimer
Premium
The Fly
Oncology stocks ‘bearing the brunt’ of Prasad news, says Oppenheimer
1M ago
IDYA
NRIX
Ideaya Biosciences announces FDA clearance for IDE849
PremiumThe Fly
Ideaya Biosciences announces FDA clearance for IDE849
1M ago
IDYA
Ideaya Biosciences reports Q1 EPS (82c), consensus (69c)
PremiumThe Fly
Ideaya Biosciences reports Q1 EPS (82c), consensus (69c)
1M ago
IDYA
IDEAYA Biosciences’ Trial Expansion and Regulatory Uncertainties Lead to Hold Rating
PremiumRatings
IDEAYA Biosciences’ Trial Expansion and Regulatory Uncertainties Lead to Hold Rating
2M ago
IDYA
IDEAYA Biosciences: Promising Prospects with Strategic Phase 3 Trial and Key Data Catalysts
PremiumRatings
IDEAYA Biosciences: Promising Prospects with Strategic Phase 3 Trial and Key Data Catalysts
2M ago
IDYA
IDEAYA Biosciences: Promising Outlook with Regulatory Alignment and Strategic Expansion in Clinical Trials
PremiumRatingsIDEAYA Biosciences: Promising Outlook with Regulatory Alignment and Strategic Expansion in Clinical Trials
2M ago
IDYA
Ideaya trial design consisent with guidance, says Oppenheimer
Premium
The Fly
Ideaya trial design consisent with guidance, says Oppenheimer
2M ago
IDYA
Morning Movers: Goldman Sachs gains following first quarter results
Premium
The Fly
Morning Movers: Goldman Sachs gains following first quarter results
2M ago
GS
BKD
Ideaya Biosciences announces FDA Type D meeting for darovasertib trial design
PremiumThe Fly
Ideaya Biosciences announces FDA Type D meeting for darovasertib trial design
2M ago
IDYA
Ideaya Biosciences initiates expansion in IDE397 trial
PremiumThe Fly
Ideaya Biosciences initiates expansion in IDE397 trial
2M ago
GILD
IDYA
IDEAYA Biosciences Announces Board Restructuring Plans
PremiumCompany Announcements
IDEAYA Biosciences Announces Board Restructuring Plans
2M ago
8K
IDYA
IDEAYA Biosciences: Buy Rating Affirmed Amid FDA Breakthrough and Promising Clinical Developments
PremiumRatings
IDEAYA Biosciences: Buy Rating Affirmed Amid FDA Breakthrough and Promising Clinical Developments
2M ago
IDYA
Ideaya Biosciences granted breakthrough therapy designation for darovasertib
PremiumThe FlyIdeaya Biosciences granted breakthrough therapy designation for darovasertib
2M ago
IDYA
Ideaya Biosciences announces research collaboration with Attmos
Premium
The Fly
Ideaya Biosciences announces research collaboration with Attmos
3M ago
IDYA
Cautious Hold Rating on IDEAYA Biosciences Amid Anticipated Equity Raises and Financial Pressures
Premium
Ratings
Cautious Hold Rating on IDEAYA Biosciences Amid Anticipated Equity Raises and Financial Pressures
3M ago
IDYA

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >